BioMark Diagnostics Inc.
BUX
株式のランク
#26698
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
株価
$0.33433516
最終同期: 2026-10-20
時価総額
$35.60M
変化（1日）
-3.08%
変化（1年）
39.31%
国
CA
取引 BioMark Diagnostics Inc. (BUX)
カテゴリー
Healthcare
BioMark Diagnostics Inc.（BUX）の株価履歴
終値の最高値: $0.38 （2026-10-01）
終値の最安値: $0.35 （2015-03-01）
終値の最安値: $0.35 （2015-03-01）
BioMark Diagnostics Inc. の株価履歴（2015 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 6.88% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.70 | 53.28% |
CN
|
|
| $177.93 | 21.98% |
US
|
